Effects of oral mitemcinal (GM-611), erythromycin, EM-574 and cisapride on gastric emptying in conscious Rhesus monkeys

Digestive Diseases and Sciences

Volumn 53, Issue 4, 2008, Pages 912-918

  Yogo, Kenji ^a   Onoma, Mitsu ^a   Ozaki, Ken Ichi ^a   Koto, Masao ^b   Itoh, Zen ^c   Omura, Satoshi ^d   Takanashi, Hisanori ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b Chugai Research Institute for Medical Science Inc   (Japan)

^c GUNMA UNIVERSITY   (Japan)

^d KITASATO INSTITUTE   (Japan)

Author keywords

Erythromycin; Gastric emptying; GM 611; Mitemcinal; Motilin; Rhesus monkey

Indexed keywords

8,9 ANHYDRO N ISOPROPYLNORERYTHROMYCIN A 6,9 HEMIACETAL; CISAPRIDE; ERYTHROMYCIN; MITEMCINAL; PARACETAMOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DYSPEPSIA; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; STOMACH EMPTYING; STOMACH PARESIS;

ACETAMINOPHEN; ADMINISTRATION, ORAL; ANALGESICS, NON-NARCOTIC; ANIMALS; CISAPRIDE; CONSCIOUSNESS; ERYTHROMYCIN; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; MACACA MULATTA; MALE;

EID: 40749147273     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9951-9     Document Type: Article

References (35)

1. Vandenplas Y, Hauser B, Salvatore S (2004) Current pharmacological treatment of gastroparesis. Expert Opin Pharmcother 5:2251-2254
2. Talley NJ (1995) Review article: functional dyspepsia-should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 9:107-115
3. Horowitz M, O'Donovan D, Jones KL, Feinle C, Rayner CK, Samsom M (2002) Gastric emptying in diabetes: clinical significance and treatment. Diabet Med 19:177-194
4. Tack J, Peeters T (2001) What comes after macrolides and other motilin stimulants? Gut 49:317-318
5. 2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther 19:379-390
6. 13C breath tests. Dig Dis Sci 40:2200-2206
7. Fraser RJ, Horowitz M, Maddox AF, Dent J (1994) Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis: effects of cisapride. Gut 35:172-178
8. Wysowski DK, Corken A, Gallo-Torres H, Rodriguez EM (2001) Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and food and drug administration regulatory actions. Am J Gastroenterol 96:1698-1703
9. Ōmura S, Tsuzuki K, Sunazuka T, Marui S, Toyoda H, Inatomi N, Itoh Z (1987) Macrolides with gastrointestinal motor stimulating activity. J Med Chem 30:1941-1943
10. Peeters TL (1993) Erythromycin and other macrolides as prokinetic agents. Gastroenterology 105:1886-1899
11. Koga H, Sato T, Tsuzuki K, Onoda H, Kuboniwa H, Takanashi H (1994) Potent, acid-stable and orally active macrolide-type motilin receptor agonists, GM-611 and the derivatives. Bioorg Med Chem Lett 4:1347-1352
12. Takanashi H, Yogo K, Ozakia K, Koga H, Itoh Z, Ōmura S (2007) In vitro pharmacological characterization of mitemcinal (GM-611), the first acid-resistant nonpeptide motilin receptor agonist, in the smooth muscle of the rabbit small intestine. Pharmacology 79:137-148
13. Ozaki K, Yogo K, Sudo H, Onoma M, Kamei K, Akima M, Koga H, Itoh Z, Ōmura S, Takanashi H (2007) Effects of mitemcinal (GM-611), an acid-resistant nonpeptide motilin receptor agonist, on the gastrointestinal contractile activity in conscious dogs. Pharmacology 79:223-235
14. Fang J, McCallum R, DiBaise J, Schmitt C, Kipnes M (2004) Effects of mitemcinal fumarate (GM-611) on gastric emptying in patients with idiopathic or diabetic gastroparesis. Gastroenterology 126:A483
15. Kipnes M, Schmitt M, DiBaise K, Fang C, Sarosiek I (2004) Safety of mitemcinal fumarate (GM-611) in patients with symptomatic gastroparesis. Diabetes 53:A132
16. McCallum RW, Goldstein BJ (2006) Diabetic gastroparesis: effect of mitemcinal by subgroup analysis in a 12-week, randomized, multi-center, double-blind, placebo-controlled, phase 2b study. Gastroenterology 130:A598
17. Yogo K, Ozaki K, Takanashi K, Koto M, Itoh Z, Ōmura S (2007) Effects of motilin and mitemcinal (GM-611) on the gastrointestinal contractile activity in Rhesus monkeys in vivo and in vitro. Dig Dis Sci doi: 10.1007/s10620-006-9672-5
18. Tsuzuki K, Sunazuka T, Marui S, Toyoda H, Ōmura S, Inatomi N, Itoh Z (1989) Motilides, macrolides with gastrointestinal motor stimulating activity. I. O-substituted and tertiary N-substituted derivatives of 8,9- anhydroerythromycin A 6,9-hemiacetal. Chem Pharm Bull 37:2687-2700
19. Itoh Z (1997) Motilin and clinical application. Peptides 18:593-608
20. Strunz U, Domschke W, Domschke S, Mitznegg P, Wunsch E, Jaeger E, Demling L (1976) Gastroduodenal motor response to natural motilin and synthetic position 13-substituted motilin analogues: a comparative in vitro study. Scand J Gastroenterol 11:199-203
21. Poitras P, Lahaie RG, St-Pierre S, Trudel L (1987) Comparative stimulation of motilin duodenal receptor by porcine or canine motilin. Gastroenterology 92:658-662
22. Guerrero-Lindner E, Arruebo MP, Murillo MD, Plaza MA (1996) Effect of motilin on gastrointestinal myoelectric activity in conscious rabbits. Peptides 17:901-907
23. Horowitz M, O'Donovan D, Jones KL, Feinle C, Rayner CK, Samsom M (2002) Gastric emptying in diabetes: clinical significance and treatment. Diab Med 19:177-194
24. Inatomi N, Sato F, Marui S, Itoh Z, Ōmura S (1996) Vagus-dependent and vagus-independent mechanisms of action of the erythromycin derivative EM574 and motilin in dogs. Jpn J Pharmacol 71:29-38
25. Sato F, Marui S, Inatomi N, Itoh Z, Ōmura S (2000) EM574, an erythromycin derivative, improves delayed gastric emptying of semi-solid meals in conscious dogs. Eur J Pharmacol 395:165-172
26. Heading RC, Nimmo J, Prescott LF, Tothill P (1973) The dependence of paracetamol absorption on the rate of gastric emptying. Br J Pharmacol 47:415-421
27. Kim DY, Myung SJ, Camilleri M (2000) Novel testing of human gastric motor and sensory functions: rationale, methods, and potential applications in clinical practice. Am J Gastroenterol 95:3365-3373
28. Willems M, Quartero AO, Numans ME (2001) How useful is paracetamol absorption as a marker of gastric emptying? A systematic literature study. Dig Dis Sci 46:2256-2262
29. Steinmetz WE, Shapiro BL, Roberts JJ (2002) The structure of erythromycin enol ether as a model for its activity as a motilide. J Med Chem 45:4899-4902
30. Hatanaka S, Kawarabayashi K, Iseri M, Tsubokura K, Furuhama K, Nijima A (1996) Comparative evaluation of DQ-2511, a novel gastroprokinetic agent, with cisapride in ameliorative action on experimentally induced delayed gastric emptying. Neurogastroenterol Motil 8:227-233
31. Tanaka T, Mizumoto A, Mochiki E, Suzuki H, Itoh Z, Ōmura S (1998) Effects of EM574 and cisapride on gastric contractile and emptying activity in normal and drug-induced gastroparesis in dogs. J Pharmacol Exp Ther 287:712-719
32. Verhagen MA, Samsom M, Maes B, Geypens BJ, Ghoos YF, Smout AJ (1997) Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers. Aliment Pharmacol Ther 11:1077-1086
33. Talley NJ, Verlinden M, Snape W, Beker JA, Ducrotte P, Dettmer A, Brinkhoff H, Eaker E, Ohning G, Miner PB, Mathias JR, Fumagalli I, Staessen D, Mack RJ (2000) Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 14:1653-1661
34. Thielemans L, Depoortere I, Perret J, Robberecht P, Liu Y, Thijs T, Carreras C, Burgeon E, Peeters TL (2005) Desensitization of the human motilin receptor by motilides. J Pharmacol Exp Ther 313:1397-1405
35. Rubinstein E (2001) Comparative safety of the different macrolides. Int J Antimicrob Agents 18(Suppl 1):S71-S76